Health Destination Pharmacy Trial – Case studies Health Destination Pharmacy Trial – Case studies | Page 14

RESULTS

3

Although this pharmacy felt that their efforts to work as a
team were yielding positive results, this was not reflected
in the financial data, which showed that after initially
promising results, there appeared to be a loss of traction
towards the end of the trial, with minor growth being
attributed to improvements in generic substitution rates
and discounting of non-PBS prescriptions.1
In terms of professional satisfaction, however, the manager reported that commencing
the MedsCheck and Clinical Interventions programs had provided the opportunity to
develop deeper rapport with local GPs.

Professional programs efforts a success

»» During the final quarter, this pharmacy provided 77 DAA services to community

“I HAVE BEEN
ENTHUSED ABOUT
REALLY CHANGING
THE CULTURE OF THE
PHARMACY TO GET
MORE CONSUMERFOCUSED CARE. ALL
THE PHARMACISTS
WERE VERY
RECEPTIVE TO THE
IDEA OF CLINICAL
INTERVENTIONS…
WE AGREED ON
A TARGET…AND
EVERYONE IS ON
BOARD”
– Pharmacy manager

14

consumers per week on average, an excellent result for a pharmacy with small script
and consumer volumes.
»» The pharmacy also provided about 14 clinical interventions per week during the
final quarter. There was an overall increase in DAA and clinical interventions claimed
during the Trial period.

Consumers benefit from workflow changes
This pharmacy experienced a small growth in customer numbers during the trial period,
compared with an overall industry loss.1 While no improvement was evident in terms
of consumer engagement, this pharmacy had the highest rating post-Trial consumer
scores in the trial group, and overall the surveys indicated consumers perceived positive
changes in all areas.

Health Destination Pharmacy Trial – Case studies I © Pharmaceutical Society of Australia Ltd.